Białecka M - Search Results

1

Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.

Białecka M, Kurzawski M, Roszmann A, Robowski P, Sitek EJ, Honczarenko K, Gorzkowska A, Budrewicz S, Mak M, Jarosz M, Gołąb-Janowska M, Koziorowska-Gawron E, Droździk M, Sławek J. Białecka M, et al. Pharmacogenet Genomics. 2012 Oct;22(10):716-24. doi: 10.1097/FPC.0b013e32835693f7. Pharmacogenet Genomics. 2012. PMID: 22890010

2

[Clinical role of the Fas/Fas ligand system].

Droździk M, Białecka M. Droździk M, et al. Among authors: bialecka m. Pol Arch Med Wewn. 1999 Apr;101(4):337-43. Pol Arch Med Wewn. 1999. PMID: 10740413 Review. Polish. No abstract available.

3

N-acetyltransferase 2 polymorphism in sporadic Parkinson's disease in a Polish population.

Bialecka M, Gawronska-Szklarz B, Drozdzik M, Honczarenko K, Stankiewicz J. Bialecka M, et al. Eur J Clin Pharmacol. 2002 Feb;57(12):857-62. doi: 10.1007/s00228-001-0415-4. Eur J Clin Pharmacol. 2002. PMID: 11936704

4

[Role of gene polymorphism of catechol-O-methyltransferase (COMT), monoamine oxidase B (MAOB), cytochrome P450 2D6 (CYP2D6) and N-acetyltransferase 2 (NAT2) in pathogenesis of Parkinson's disease].

Białecka M, Droździk M, Podraza H. Białecka M, et al. Neurol Neurochir Pol. 2002 Jan-Feb;36(1):113-21. Neurol Neurochir Pol. 2002. PMID: 12053603 Review. Polish.

5

Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease.

Droździk M, Białecka M, Myśliwiec K, Honczarenko K, Stankiewicz J, Sych Z. Droździk M, et al. Among authors: bialecka m. Pharmacogenetics. 2003 May;13(5):259-63. doi: 10.1097/01.fpc.0000054087.48725.d9. Pharmacogenetics. 2003. PMID: 12724617

6

The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease.

Białecka M, Droździk M, Kłodowska-Duda G, Honczarenko K, Gawrońska-Szklarz B, Opala G, Stankiewicz J. Białecka M, et al. Acta Neurol Scand. 2004 Oct;110(4):260-6. doi: 10.1111/j.1600-0404.2004.00315.x. Acta Neurol Scand. 2004. PMID: 15355491

7

Analysis of MDR1 haplotypes in Parkinson's disease in a white population.

Tan EK, Drozdzik M, Bialecka M, Honczarenko K, Klodowska-Duda G, Teo YY, Tang K, Wong LP, Chong SS, Tan C, Yew K, Zhao Y, Lee CG. Tan EK, et al. Among authors: bialecka m. Neurosci Lett. 2004 Dec 6;372(3):240-4. doi: 10.1016/j.neulet.2004.09.046. Neurosci Lett. 2004. PMID: 15542248

8

Catechol-O-methyltransferase and monoamine oxidase B genes and susceptibility to sporadic Parkinson's disease in a Polish population.

Białecka M, Droździk M, Honczarenko K, Gawrońska-Szklarz B, Stankiewicz J, Dabrowska E, Kubisiak M, Kłodowska-Duda G, Opala G. Białecka M, et al. Eur Neurol. 2005;53(2):68-73. doi: 10.1159/000084302. Epub 2005 Mar 7. Eur Neurol. 2005. PMID: 15753616

9

Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients.

Kurzawski M, Droździk M, Suchy J, Kurzawski G, Białecka M, Górnik W, Lubiński J. Kurzawski M, et al. Among authors: bialecka m. Eur J Clin Pharmacol. 2005 Jul;61(5-6):389-94. doi: 10.1007/s00228-005-0926-5. Epub 2005 May 24. Eur J Clin Pharmacol. 2005. PMID: 15912392

10

Analysis of LRRK 2 G 2019 S and I 2020 T mutations in Parkinson's disease.

Bialecka M, Hui S, Klodowska-Duda G, Opala G, Tan EK, Drozdzik M. Bialecka M, et al. Neurosci Lett. 2005 Dec 16;390(1):1-3. doi: 10.1016/j.neulet.2005.07.045. Neurosci Lett. 2005. PMID: 16115731 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page